A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis
Clinical trial NCT05695950 · COMPLETED
Trial details
- NCT number
- NCT05695950
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-27
- Primary completion
- 2025-10-13
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.